MyPeptide sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.

ARA-290 (Cibinetide) is an 11-amino-acid peptide derived from the helix-B domain of erythropoietin, studied for tissue protection and neuropathic pain in research models without erythropoietic activity.
For laboratory and research use only. Not for human or veterinary use.
Activates the innate repair receptor (IRR), a heteromer of EPO receptor and CD131, triggering anti-inflammatory and tissue-protective pathways without stimulating red blood cell production.
| sequence | 11-aa EPO-derived peptide (Cibinetide) |
| molecular Weight | ~1250 Da |
| appearance | White lyophilized powder |
Reconstitute with bacteriostatic water under sterile conditions.
Lyophilized: 2–8 °C. Reconstituted: refrigerate.
Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.